Currently holds a position at Momenta Pharmaceuticals Inc
Position | Company | Period |
---|---|---|
Chief Financial Officer, Treasurer | Momenta Pharmaceuticals Inc | Oct. 1, 2018 - |
Chief Financial Officer, Treasurer | Momenta Pharmaceuticals Inc | Oct. 1, 2018 - Jan. 8, 2020 |
Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer | Momenta Pharmaceuticals Inc | May 1, 2017 - Oct. 1, 2018 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2023-05-15 | 2023-05-11 |
Editas Medicine Inc
(EDIT)
|
S Sale |
949
-0.9%
9.879,369 USD |
949 -0.9% | 9.87 | 9,369 USD | |
2023-03-06 | 2023-03-03 |
Editas Medicine Inc
(EDIT)
|
S Sale |
184
-0.2%
8.891,636 USD |
184 -0.2% | 8.89 | 1,636 USD | |
2023-02-15 | 2023-02-13 |
Editas Medicine Inc
(EDIT)
|
S Sale |
4,287
-5.3%
9.6741,435 USD |
4,287 -5.3% | 9.67 | 41,435 USD | |
2022-12-06 | 2022-12-05 |
Editas Medicine Inc
(EDIT)
|
S Sale |
193
-0.2%
10.231,974 USD |
193 -0.2% | 10.23 | 1,974 USD | |
2022-09-08 | 2022-09-06 |
Editas Medicine Inc
(EDIT)
|
S Sale |
192
-0.2%
15.012,882 USD |
192 -0.2% | 15.01 | 2,882 USD | |
2022-06-06 | 2022-06-03 |
Editas Medicine Inc
(EDIT)
|
S Sale |
1,527
-1.8%
11.5417,617 USD |
1,527 -1.8% | 11.54 | 17,617 USD | |
2022-03-07 | 2022-03-03 |
Editas Medicine Inc
(EDIT)
|
S Sale |
767
-0.9%
17.3313,290 USD |
767 -0.9% | 17.33 | 13,290 USD | |
2022-01-13 | 2022-01-11 |
Editas Medicine Inc
(EDIT)
|
S Sale |
1,744
-5.3%
25.7044,821 USD |
1,744 -5.3% | 25.70 | 44,821 USD | |
2021-01-13 | 2021-01-12 |
Editas Medicine Inc
(EDIT)
|
S Sale |
1,568
-7.8%
78.27122,727 USD |
1,568 -7.8% | 78.27 | 122,727 USD | |
2019-10-29 | 2019-10-25 |
Momenta Pharmaceuticals Inc
(MNTA)
|
PS Planned sale |
6,802
-50.0%
15.00102,030 USD |
6,802 -50.0% | 15.00 | 102,030 USD | |
2019-10-21 | 2019-10-18 |
Momenta Pharmaceuticals Inc
(MNTA)
|
PS Planned sale |
2,936
-17.7%
13.8340,605 USD |
2,936 -17.7% | 13.83 | 40,605 USD | |
2019-02-19 | 2019-02-14 |
Momenta Pharmaceuticals Inc
(MNTA)
|
PS Planned sale |
703
-5.7%
13.109,209 USD |
703 -5.7% | 13.10 | 9,209 USD | |
2019-02-14 | 2019-02-13 |
Momenta Pharmaceuticals Inc
(MNTA)
|
PS Planned sale |
1,410
-10.3%
12.7017,907 USD |
1,410 -10.3% | 12.70 | 17,907 USD |